Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Segment Highlights
IQV logo

IQVIA Revenues Climb 5.2% to $4.1B Amid AI Investments and R&D Backlog Growth

IQV10-QFiling Date: 10/28/2025
IQVIA Holdings Inc.
Description

What this story covers

IQVIA's Q3 2025 10-Q shows 5.2% revenue growth to $4.1B, driven by tech analytics and clinical R&D. Backlog hits $32.4B for future visibility. Liquidity strong at $1.8B cash; debt refinanced for stability. Strategic AI focus enhances data-driven healthcare services amid steady risks.

Story snapshot

CompanyIQVIA Holdings Inc.
TickerIQV
VariantStandard detailed
Duration10:26
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001628280-25-046794

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in